Table 2.

Two-way repeated measures ANOVA used to analyze effects of post-session mAChR blockade on different measures of the operant discrimination task.

Variable	Training stage	Effect	F value	p value	Post hoc analysis
Rewards	Tone training	Day	6.38	1.39 × 10−4	No sig. differences between scop and saline groups
		Drug	0.025	0.88
		Day by Drug	4.40	7.00 × 10−3
	Discrimination training	Day	63.30	2.24 × 10−19	Saline is sig. different from scop on days 11, 12, 14–16 (p < 0.05)
		Drug	9.94	4.60 × 10−3
		Day by Drug	5.72	2.00 × 10−3
Incorrect NPs	Tone training	Day	6.68	9.87 × 10−4	No sig. differences between scop and saline groups
		Drug	0.21	0.65
		Day by Drug	1.81	0.15
	Discrimination training	Day	61.57	2.46 × 10−26	Saline is sig. different from scop on days 15 and 17 (p < 0.05)
		Drug	0.28	0.60
		Day by Drug	5.69	2.74 × 10−4
Inactive NPs	Tone training	Day	14.68	1.20 × 10−5	No sig. differences between scop and saline groups
		Drug	0.27	0.61
		Day by Drug	0.14	0.90
	Discrimination training	Day	5.25	5.83 × 10−4	No sig. differences between scop and saline groups
		Drug	0.22	0.65
		Day by Drug	1.27	0.28
Tones	Tone training	Day	1.45	0.24	No sig. differences between scop and saline groups
		Drug	0.42	0.52
		Day by Drug	1.22	0.31
	Discrimination training	Day	22.91	2.13 × 10−14	Saline is sig. different from scop on days 15–17 (p < 0.05)
		Drug	5.49	0.03
		Day by Drug	5.65	2.14 × 10−4
Hit rate	Tone training	Day	5.95	2.35 × 10−3	No sig. differences between scop and saline groups
		Drug	0.04	0.85
		Day by Drug	4.98	3.50 × 10−3
	Discrimination training	Day	40.32	2.24 × 10−22	No sig. differences between scop and saline groups
		Drug	7.58	0.01
		Day by Drug	1.71	0.04
Receptacle Entries	Tone training	Day	6.74	2.10 × 10−3	No sig. differences between scop and saline groups
		Drug	1.60	0.22
		Day by Drug	0.77	0.52
	Discrimination training	Day	9.73	2.55 × 10−21	No sig. differences between scop and saline groups
		Drug	1.34	0.26
		Day by Drug	0.46	0.97